Objective: Reduction of melanocortin signaling in the brain results in obesity. However, where in the brain reduced melanocortin signaling mediates this effect is poorly understood. Design: We determined the effects of long-term inhibition of melanocortin receptor activity in specific brain regions of the rat brain. Melanocortin signaling was inhibited by injection of a recombinant adeno-associated viral (rAAV) vector that overexpressed Agouti-related peptide (AgRP) into the paraventricular nucleus (PVN), the ventromedial hypothalamus (VMH), the lateral hypothalamus (LH) or the accumbens shell (Acc). Results: Overexpression of AgRP in the rat PVN, VMH or LH increased bodyweight, the percentage of white adipose tissue, plasma leptin and insulin concentrations and food intake. Food intake was mainly increased because of an increase in meal size in the light and dark phases, after overexpression of AgRP in the PVN, LH or VMH. Overexpression of AgRP in the PVN or VMH reduced average body core temperature in the dark on day 40 post injection, whereas AgRP overexpression in the LH did not affect temperature. In addition, overexpression of AgRP in the PVN, LH or VMH did not significantly alter mRNA expression of AgRP, neuropeptide Y (NPY), pro-opiomelanocortin (POMC) or suppressor of cytokine signaling 3 (SOCS3) in the arcuate. Overexpression of AgRP in the Acc did not have any effect on the measured parameters. Conclusions: Reduction of melanocortin signaling in several hypothalamic regions increased meal size. However, there were brain area-specific effects on other parameters such as core temperature and plasma leptin concentrations. In a previous study, where NPY was overexpressed with an rAAV vector in the PVN and LH, meal frequency and meal size were increased respectively, whereas locomotor activity was reduced by NPY overexpression at both nuclei. Taken together, AgRP and NPY have complementary roles in energy balance.
Introduction
Overconsumption has an important role in the current obesity epidemic. One of the major neuropeptides that stimulates food intake is Agouti-related peptide (AgRP). AgRP is produced in neurons within the arcuate nucleus of the hypothalamus and functions as an inverse agonist at the melanocortin 3 and 4 receptors (MC3R and MC4R). 1, 2 Constitutive inhibition of the MC-Rs through ectopic overexpression of AgRP or agouti, or central infusion of AgRP, results in hyperphagia and reduces energy expenditure. [3] [4] [5] [6] [7] [8] Furthermore, knockout studies have shown that reduced activity of the MC3R and MC4R contribute to obesity and these receptors have additive effects when both are deleted. [9] [10] [11] [12] [13] [14] Although reduced activation of brain MC-Rs results in obesity, it is poorly understood where in the brain this effect is mediated as the MC-Rs are expressed in multiple sites of the brain. [15] [16] [17] We previously showed that ectopic overexpression of Agouti in the paraventricular nucleus (PVN) of rats resulted in hyperphagia and obesity. 8 In addition, local acute injection studies with AgRP 83À132 and MC-R antagonists in different brain nuclei demonstrated that when MC-R activity is reduced, food intake is stimulated. [18] [19] [20] Thus, multiple brain regions are involved in the effects of MC-Rs on food intake. It is, however, unclear whether chronic inhibition of MC-R activity in these different nuclei contributes to the development of obesity. Ligands can be delivered precisely to hypothalamic nuclei using minipumps and guided canula; however, this approach is hampered because the buildup of pressure may spread the ligands further than the nucleus of interest and the tips of the needles are easily blocked by gliosis. Therefore, as an alternative strategy, we chose viral-mediated delivery of neuropeptides.
To investigate whether the effects of long-term inhibition of MC-R activity are brain site specific, we used adeno-associated viral (AAV) vector-mediated gene transfer to deliver AgRP to the PVN, the lateral hypothalamus (LH), the ventromedial hypothalamus (VMH) and the nucleus accumbens shell (Acc), which are all brain regions with high levels of MC receptor expression [15] [16] [17] and an established role in the regulation of energy balance. 21 After injection of recombinant AAV (rAAV)
particles containing AgRP-ires-GFP (AAV-AgRP) or green fluorescent protein (GFP; AAV-control) complementary DNA (cDNA) in the PVN, LH, VMH or Acc, rats were monitored for 50 days. During this time, the effects on body weight, caloric intake (including meal patterns), locomotor activity and body core temperature were examined. At the end of the experiments, the effects on white adipose tissue and endocrine parameters were analyzed. In addition, we carefully compared the effects of overexpression of AgRP in the LH and PVN with data from a previous study in which neuropeptide Y (NPY) was overexpressed in the LH and PVN with an AAV vector. 22 We injected the AAV-AgRP directly into the target area because previous studies in our lab, using a similar strategy to overexpress neuropeptides, showed that immunostaining was limited to the injection area and was not observed in the projection areas.
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Materials and methods
Cell lines, plasmids and virus
Human embryonic kidney 293T cells were maintained at 37 1C with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 2 mM glutamine, 100 units ml -1 penicillin, 100 units ml -1 streptomycin and non-essential amino acids. pAAV-CBA-GFP-WPRE with AAV2 inverted terminal resolutions sites, as previously described by Broekman et al. 24 was a kind gift from M Sena-Esteves. pAAV-CBA-flAgRP-ires-GFP was constructed by cloning the full-length mouse Agouti-related protein (AgRP) cDNA in pIRES2-EGFP (Clontech, Leusden, The Netherlands). Subsequently, AgRP-ires-EGFP was isolated and ligated in pAAV-CBA-GFP-WPRE after removal of GFP from the AAV plasmid. The pDP1 helper plasmid has been described previously 25 and was obtained from Plasmid factory (Bielefield, Germany). AAV production was performed as described previously. 26 The titer obtained for AAV-CBA-GFP-WPRE (AAV-control) was 9.9 Â 10 12 genomic copies per ml and for AAV-CBA-flAgRP-ires-GFP (AAV-AgRP) was 1.7 Â 10 14 genomic copies per ml.
Animals
Male Wistar rats, weight ranging from 220 to 250 g, were purchased from Charles River (Crl-Wu, Sulzfeld, Germany). All rats were individually housed in filter-top cages with ad libitum access to food (CRM pellets; Special Diet Services, Whitham, Essex, UK) and water. Animals were kept in a temperature-and humidity-controlled room (temperature 21±2 1C, humidity 55±5%) with a 12 h light/dark cycle (lights on at 0700 hours). All experimental procedures were approved by the Committee for Animal Experimentation of the University of Utrecht (Utrecht, The Netherlands). Carprofen) subcutaneous; Pfizer Animal Health, Capelle a/d IJssel, the Netherlands) was administered as pain medication, before surgery and for 2 days after. During surgery, the rats received an abdominal transmitter (TA10TA-F40; Data Science International, St Paul, MN, USA) to measure temperature and activity. Immediately after transmitter placement the rats were injected bilaterally in the different brain areas with the use of a stereotact. In all, 25 rats were injected in the PVN (coordinates anterior posterior (AP) À1.8 mm from bregma; mediolateral (ML) ±1.7 mm from bregma; and dorsoventral (DV) À8.2 mm below the skull; with 10 1 angle), 9 rats were injected with AAV-GFP and 16 with AAV-AgRP. In addition, 22 rats were injected in the LH (coordinates AP À2.6, ML ± 2.0 and DV À8.6), 9 rats were injected with AAV-GFP and 13 with AAV-AgRP. A total of 21 rats were injected in the VMH (coordinates AP À2.6, ML ± 1.2 and DV À9.4, with 5 1 angle), 9 rats were injected with AAV-GFP and 12 with AAV-AgRP. Finally, 21 rats were injected in the shell of the Acc (coordinates AP þ 1.2, ML ± 2.8 and DV À8.0, with 10 1 angle), 9 rats were injected with AAV-GFP and 12 with AAV-AgRP. Per site, 1 ml of virus containing 1 Â 10 9 genomic copies of rAAV was injected at a rate of 0.2 ml min -1 . After the injection, the needle was kept in place for 10 min before removal.
Surgical procedures

Data recordings
After viral injections the rats were monitored for approximately 50 days for the effects on bodyweight, food intake, body core temperature and locomotor activity. Bodyweight gain and food intake were measured three times a week at 1000 hours Core temperature and locomotor activity were automatically recorded via transmitters that sent digitized data to a nearby receiver. These data were recorded every 10 min using DSI software (Data Science International). Collection of blood and tissues At days 48-50, rats were decapitated in the morning and trunk blood was collected in heparinized tubes containing 83 mmol EDTA and 1 mg aprotinin. The blood was immediately placed on ice. After centrifugation blood plasma was stored at À20 1C until additional analysis. After decapitation the brains were immediately removed, quickly frozen on dry ice and stored at À80 1C. Retroperitoneal, epididymal, mesenteric and subcutaneous white adipose tissues were isolated and weighed, as well as adrenals and thymus.
DIG in situ hybridization
To verify injection sites, brains were sectioned on a cryostat into 20 mm thick slices. Every tenth section was used for in situ hybridization with a 720-bp-long digoxigenin (DIG)-labeled enhanced GFP riboprobe (antisense to NCBI (National Center for Biotechnology Information) gene DQ768212). The in situ hybridization was performed as described by Schaeren-Wiemers and Gerfin-Moser 27 with small modifications in the fixation procedure and hybridization temperature. Briefly, sections were fixed in 4% paraformaldehyde for 20 min and rinsed three times for 3 min in phosphate-buffered saline. After acetylation for 10 min (0.25% acetic anhydride in 0.1 M triethanolamine), the sections were washed three times in phosphate-buffered saline for 5 min and prehybridized at room temperature in hybridization solution containing 50% deionized formamide, 5 Â sodium chloride sodium citrate buffer (SSC), 5 Â Denhardt's solution, 250 mg ml -1 transfer RNA Baker's yeast and 500 mg ml -1 sonificated salmon sperm DNA. After 2 h, 150 ml of hybridization mixture containing 400 ng ml -1 DIG-labeled riboprobe was applied per slide, covered with Nescofilm and hybridized overnight at 72 1C. The next morning the slides were quickly washed in 2 Â SSC followed by 0.2 Â SSC for 2 h, and both these wash steps were performed at 72 1C. DIG was detected with an alkaline phosphatase-labeled antibody (1:5000; Roche, Mannheim, Germany) using nitroblue tetrazolium and bromochloroindolylphosphate (NBT/BCIP; Sigma, Zwijndrecht, The Netherlands) as a substrate. After overnight incubation at room temperature with NBT/BCIP mixture, sections were quickly dehydrated in ethanol, cleared in xylene and mounted using Entellan.
Radioactive in situ hybridization Adjacent cryostat brain sections were used for radioactive in situ hybridization with 33 P-labeled antisense RNA probes for AgRP (396 bp mouse AgRP cDNA), 28 NPY (287 bp rat NPY cDNA), pro-opiomelanocortin (POMC, 350 bp rat POMC cDNA fragment), 28 suppressor of cytokine signaling 3 (SOCS3, 1200 bp SOCS3 cDNA). The procedure for radioactive in situ hybridization and analysis has been described previously. 29 
Plasma analysis
Plasma concentrations leptin and insulin were measured in duplicate using radioimmunoassay kits (Millipore, Billerica, MA, USA). Plasma glucose was analyzed in triplicate using a glucose/GOD-perid method (Boehringer Mannheim, Mannheim, Germany).
Statistical analysis
Data are presented as group means ± s.e.m. Differences in bodyweight and food intake were assessed using repeated measure analysis with post hoc Bonferonni tests. Additional statistical analysis was performed with two-sided t-test. Differences were considered significant at Po0.05.
Results
Localization of rAAV injections
In situ hybridization with a DIG-labeled GFP probe was performed for each rat to verify injection sites (Supplementary Figure 1 ). Rats injected with AAV-AgRP were only included in the study when GFP signals were observed bilaterally in the Acc (AP between þ 2.2 and þ 0.7 mm; ML between 1 and 2 mm from bregma), PVN (AP between À1.3 and À2.3 mm; ML between 0 and 1 mm from bregma), VMH (AP between À2.1 and À3.6 mm; ML between 0.2 and 1 mm) or LH (AP between À2.3 and À3.8 mm; ML between 1 and 2.5 mm from bregma). Bilateral injection of AAV-AgRP was confirmed for 8 rats in the PVN, 7 rats in the VMH, 9 rats in the LH and 10 rats for the Acc. Unilateral injections were observed in 5 rats in the PVN, 5 rats in the VMH, 4 rats in the LH and 2 rats in the Acc. Unilateral and missed injections of AAV-AgRP were analyzed separately and are indicated as such. As expression of AAV-control was expected to have no effects on energy balance, we tested whether there were differences between the bilateral and unilateral transduced AAV-control rats. This showed that there were no differences between bilateral and unilateral control rats. In addition, control rats in different groups (PVN, VMH, LH and Acc) also displayed similar amounts of bodyweight gain, food intake and meal patterns, supporting the assumption that expression of AAV-control had no effects on energy balance.
Effects or rAAV-AgRP on body weight and food intake All injection groups showed a similar transient decrease in body weight gain, caloric intake and water intake in the days Figure 1d ). In addition, when AgRP expression was mistargeted (for instance, when GFP expression was too rostral or caudal of the PVN; missed PVN injection), then there was no increase in body weight gain (Figure 1e ). At the end of the experiment PVN-AgRP, LH-AgRP and VMH-AgRP rats had accumulated 80% more body weight compared with controls (PVN: 79.8% ( ± 17.2) P ¼ 0.0002; LH: 80.1% (±10.1) Po0.0001; and VMH 78.8% (±12.6) Po0.0001).
During the second week, the PVN-AgRP, LH-AgRP and VMH-AgRP rats all increased their daily food intake compared with controls. Food intake remained significantly elevated during the course of the experiment (Figures 2a-c) . Daily food intake in the Acc-AgRP and missed PVN-AgRP groups were similar to control groups (Figures 2d and e) .
Daily water intake of PVN-AgRP and VMH-AgRP rats followed the food intake pattern and was significantly increased compared with controls from days 20 and 23, respectively (PVN-AgRP average of 28.2±1.0 vs 24.3±0.5 ml day -1 for PVN-control; VMH-AgRP average of 26.5 ± 0.9 vs 21.9 ± 0.5 ml day -1 for VMH-control). LH-AgRP and Acc-AgRP rats did not differ in water intake compared with their controls (data not shown).
Effects of rAAV-AgRP on meal patterns
The PVN-AgRP, VMH-AgRP and LH-AgRP rats showed a significant increase in 24 h food intake at days 20 and 40 (Figures 3a, 4a and 5a). This was because of an increase in To investigate if the increase in daily food intake was because of a difference in the number of meals (meal frequency, a measure of meal initiation) or in meal size (a measure of satiation), meal patterns were analyzed on days 20 and 40. Day 20 was analyzed in detail because gene expression from a rAAV vector increased during the first weeks and reached a plateau after 2 to 3 weeks (depending on AAV serotype and tissue). [30] [31] [32] Day 40 was chosen to compare the results with an earlier study, in which AAVmediated overexpression of NPY in the PVN resulted in compensatory changes after day 20, which caused increased food intake and body weight gain to return to control levels at day 40.
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On days 20 and 40, the 24 h meal size of PVN-AgRP, VMH-AgRP and LH-AgRP was significantly increased compared with controls ( Figures 3d, 4d and 5d ), whereas the 24 h meal frequency was similar to the respective control groups (Figures 3g, 4g and 5g) . Both 24 h meal size and frequency were not different between Acc-AgRP and Acc-control rats (Figures 6d and g ).
On day 20, the increase in 24 h food intake in PVN-AgRP rats was because of a significant increase in size and frequency in the light phase only (Figures 3e and h) . On day 40, the increase in 24 h food intake of PVN-AgRP Local AgRP overexpression in the brain MWA de Backer et al rats was because of a significant increase in meal size in both the light and dark phases (Figure 3f ). In addition, the frequency in the light phase was still increased in PVN-AgRP rats compared with PVN-control rats (Figure 3i) .
The VMH-AgRP rats showed an increase in food intake on days 20 and 40. This increase was because of an increase in meal size in both the light and dark phases (Figures 4e and f) . There was no difference between VMH-AgRP and VMHcontrol rats in meal frequency on days 20 and 40 (Figures 4h  and i) .
The increase in food intake of LH-AgRP rats on day 20 was because of an increase in meal size, which was statistically significant in the dark phase (Figure 5e ). There was no effect on meal frequency in the light or dark phases (Figure 5h ). On day 40, the increase in food intake of LH-AgRP rats was caused by increased meal size in both the light and dark phases (Figure 5f ). There was no difference in frequency between LH-AgRP and LH-control rats (Figure 5i ).
The Acc-AgRP rats were similar to Acc-control rats in meal size and frequency on both days in both the light and dark phases (Figures 6e-i) .
Effects of rAAV-AgRP on body core temperature and locomotor activity rAAV-AgRP had only modest effects on body core temperature and activity (Table 1 ). In the dark phase of day 40, the core temperature of PVN-AgRP rats was significantly decreased. In addition, the temperature of VMH-AgRP rats was decreased in the dark phase of day 40. LH-AgRP and AccAgRP rats were similar in body temperature to their controls in both light and dark phases of days 20 and 40.
Locomotor activity was decreased in the dark phase of days 20 and 40 in PVN-AgRP rats ( Table 1 ). The LH-AgRP and Acc-AgRP rats showed no significant differences in their locomotor activity compared with their controls, whereas VMH-AgRP rats tended (P ¼ 0.1542) to decrease locomotor activity at day 20 in the dark phase. 
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Effects of rAAV-AgRP on endocrine parameters and body composition
The effects of AgRP overexpression in the different brain areas on body composition and plasma hormone concentrations are summarized in Table 2 . PVN-AgRP, LH-AgRP and VMH-AgRP rats all had significantly increased amounts of subcutaneous and abdominal white adipose tissues compared with controls. Similarly, plasma concentrations of leptin and insulin were significantly increased for each of these groups. However, plasma leptin concentrations of PVN-AgRP and VMH-AgRP rats were significantly higher than leptin concentrations of LH-AgRP rats (P ¼ 0.0253 LH-AgRP vs PVN-AgRP; P ¼ 0.0431 LH-AgRP vs VMH-AgRP). Rats injected with AgRP in the Acc shell did not show any significant differences from controls. Furthermore, no differences were observed in plasma glucose concentrations or adrenal weights for any of the AgRP group. However, the weight of the thymus was decreased in PVN-AgRP rats compared with controls.
Effects of rAAV-AgRP on neuropeptide expression
There were no differences in NPY, AgRP, POMC and SOCS3 mRNA levels in the arcuate nucleus between rAAV-AgRP rats and their controls after injection of rAAV vectors in the PVN, VMH and LH (NPY mRNA levels: PVN-control 100 ± 6. Local AgRP overexpression in the brain MWA de Backer et al
Discussion
Reduced brain MC-R activity results in increased food intake and obesity, but it was poorly understood where in the brain these effects were mediated. In this study we showed that long-term inhibition of the MC-R, by overexpression of AgRP, in PVN or VMH or LH increased body weight gain, fat mass and food intake. Food intake was mainly increased by an increase in meal size. The increase in caloric intake was clearly not an effect of global overexpression of AgRP in the hypothalamus, because rats with mistargeted AgRP overexpression in the hypothalamus were not different from controls. Together, these results suggest that chronic inhibition of MC-R activity at multiple sites in the hypothalamus contributes to the hyperphagia and obesity that are associated with reduced MC-R activity in knockout models and humans with mutations in MC4R. This is in agreement with data from short-term local injections in the LH, VMH and PVN, which showed an increase in food intake after injection of AgRP 83À132 in these areas. [18] [19] [20] In contrast, re-expression of the MC4R in the PVN and amygdala, which normalized the hyperphagia seen in MC4R À/À mice, suggested that the PVN and amygdala are sufficient for the anorectic effect of melanocortins. 33 However, regaining MC sensitivity in a MC4R knockout background clearly differs from reducing MC sensitivity in a wild-type background, as was performed in this study. Our current study indicates that the PVN is probably not the only hypothalamic nucleus that contributes to hyperphagia when MC-R activity is reduced. AgRP overexpression in the Acc shell did not have any effect on caloric intake, body weight gain or any other parameter measured in this study. This is in agreement with a previous study that showed that injections of the MC4R antagonist HS014 in the Acc did not alter food intake. 34 Effects on meal patterns Hyperphagia can result from an increase in meal size or an increase in meal number or both. It has been hypothesized that meal size is a measure for satiation and that the number Abbreviations: AAV, adeno-associated viral; Acc, accumbens shell; AgRP, Agouti-related peptide; GFP, green fluorescent protein; LH, lateral hypothalamus; PVN, paraventricular nucleus; VMH, ventromedial hypothalamus. *Po0.05 versus control group.
Local AgRP overexpression in the brain MWA de Backer et al meals over the light-dark cycle, with more meals consumed in the light period, whereas total 24 h frequency was not affected. The increase in meal size observed in this study is in accordance with previous studies that showed that MC-R antagonist increased meal size and not meal frequency. [37] [38] [39] In addition, an agonist for the MC3R and MC4R specifically reduced meal size and not meal frequency. [39] [40] [41] Taken together, our data suggest that inhibition of MC-R activity in the PVN, LH and VMH decreases satiation irrespective of the time of day. This effect on satiation has also been reported in humans with MC4R deficiency. During an ad libitum test meal, these patients eat larger meals, indicating a decrease in satiation, similar to our observations.
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Effects on body temperature and locomotor activity Body temperature was differentially affected by AgRP depending on the area in which it was overexpressed. AgRP overexpression in the PVN or VMH reduced body temperature in the dark phase of day 40, whereas AgRP overexpression in the LH or Acc did not change body temperature. The decrease in body temperature shown in PVN and VMH rats may be because of the reduced levels of locomotor activity observed in these rats. A decrease in locomotor activity and core body temperature was previously reported after intracerebroventricular administration of AgRP 83À132 , 37, 43 and administration of MC agonist in the PVN increased spontaneous locomotor activity and core temperature. 44 In addition, 6-month-old AgRP-deficient mice were reported to be hyperactive. 45 However, re-expression of MC4R in the PVN and amygdala of MC4R À/À mice had no effects on locomotor activity.
MC3R
À/À mice do show a decrease in locomotor activity and MC3Rs are also expressed in the PVN. 13, 14, 17 Therefore, reductions in locomotor activity by AgRP may be because of inhibition of MC3R.
Effects on body composition and endocrine parameters
The increase in body weight by AgRP overexpression in PVN, LH and VMH was reflected in the amount of white fat mass, which was also increased. As expected with larger fat mass, the plasma leptin concentrations were increased in these groups. However, leptin concentrations in PVN-AgRP and VMH-AgRP rats were significantly higher than leptin concentrations in the LH-AgRP rats, whereas all rats had comparable abdominal and subcutaneous white adipose tissue percentages. A decrease in sympathetic nervous system (SNS) activity may have contributed to the increase in leptin secretion in VMH and PVN rats. Retrograde tracing experiments have shown that PVN, LH and VMH are connected to adipose tissue [46] [47] [48] and 60% of these projections from the brain to white and brown adipose tissues coexpress MC4R mRNA. 47, 48 In addition, obese MC4R À/À mice and humans were reported to have decreased SNS activity 49, 50 and intracerebroventricular administration of MC-R ligands affected SNS activity. 51 Lesions in the VMH and PVN increase food intake and decrease sympathetic activity, whereas lesions in the LH decrease food intake and increase sympathetic activity. [52] [53] [54] [55] [56] Thus, the SNS activity is controlled in a similar manner in VMH and PVN, which clearly differs from LH. The SNS activity is relayed to the periphery via noradrenalin that binds b-adrenoreceptors, and in vitro studies showed that b-receptor agonists decreased leptin secretion by adipocytes. 57, 58 Therefore, overexpression of AgRP in the LH may increase the levels of SNS activity, thereby decreasing leptin secretion by adipocytes, whereas AgRP in the PVN and VMH decreases SNS activity and increases leptin secretion relative to the amount of white adipose tissue. In addition to the increased plasma leptin concentrations after overexpression of AgRP in hypothalamic nuclei, plasma insulin concentrations were also increased, but to a similar level in all three nuclei. Moreover, plasma glucose concentrations were not altered between the AgRP-injected and control (GFP)-injected rats, suggesting insulin resistance. As these levels were measured at the end of the experiment when rats with AgRP overexpression were obese, this could well be an indirect effect of the occurring obesity on glucose metabolism.
This study investigated the effects of inhibition of MC signaling on several hypothalamic nuclei and a forebrain Local AgRP overexpression in the brain MWA de Backer et al nucleus. However, there are also MC receptors in several nuclei in the hindbrain that can mediate effects on food intake, locomotor activity and core temperature. 44 These data together with the current study suggest that MC signaling in different hypothalamic and hindbrain nuclei contribute to different aspects of energy balance.
Comparison with AAV-mediated overexpression of NPY The orexigenic peptides, NPY and AgRP, are produced by the same neurons in the arcuate nucleus and NPY1R and MC4R colocalize in several brain areas, for example, PVN and central amygdala. 59 Thus, one might expect that NPY and AgRP overexpression act similarly at projection sites of the arcuate nucleus to increase food intake and body weight. To test the validity of this assumption, we compared our current data on AgRP overexpression in the LH and PVN with previous data on NPY overexpression in the same areas. 22 In the PVN, clear differences were found between overexpression of the two peptides. Overexpression of NPY in the PVN temporarily increased food intake, but because of compensatory mechanisms, food intake returned to control levels. 60 The temporary increase in food intake was caused by a transient increase in meal frequency in the light period only. In contrast, AgRP overexpression in the PVN increased food intake during the entire experiment and was because of increase in meal size in both the light and dark periods as well as an increase in meal frequency during the light period.
In the LH, both overexpression of NPY and AgRP increased food intake because of an increase in meal size without affecting meal frequency, during the entire experiment. Thus, in the LH, AgRP and NPY show similar effects on meal patterns. However, energy expenditure appears to be differently regulated; overexpression of NPY in LH decreased locomotor activity and core body temperature, whereas AgRP overexpression in the LH did not affect these parameters.
Overexpression of NPY in both LH and PVN decreased the endogenous expression of AgRP mRNA in the arcuate nucleus, whereas overexpression of AgRP did not affect POMC, NPY, SOCS3 or AgRP mRNA in the arcuate. This suggests that the effects of NPY overexpression can be partially compensated by an increase in MC-R signaling, whereas the effects of AgRP overexpression are not compensated by a decrease in NPY signaling.
The increased meal size, which is associated with reduced MC-R activity, is distributed over distinct hypothalamic nuclei. Nevertheless, there were brain area-specific effects of AgRP on locomotor activity, body temperature, diurnal rhythm of food intake and plasma leptin concentrations. Future research has to indicate which effects of AgRP overexpression are mediated by MC4R or MC3R or both. Finally, comparison of AgRP overexpression data with previous data of NPY overexpression showed that although NPY and AgRP are co-released by ARC neurons, they probably affect food intake and energy expenditure through different mechanisms.
